Mainz Biomed BV (MYNZ)

[BlazingStocks]

Already a good start to the day...


$MYNZ Flagship product ColoAlert...
*Announced receiving supportive feedback from the FDA on ColoAlert's pre-submission package
*Initiating and enrolling the first patient in an international clinical study (ColoFuture)
*Evaluating the integration of novel mRNA biomarkers into ColoAlert.
https://www.marketwatch.com/press-release/mainz-biomed-targets-multi-billion-dollar-sales-opportunities-with-best-in-class-cancer-screening-diagnostics-mynz-2022-09-26

[BlazingStocks]

$MYNZ had a nice green day yesterday on News...

$MYNZ Flagship product ColoAlert...
*An accurate, non-invasive, and easy-to-use early detection diagnostic test for colorectal cancer
*Generating revenues, marketed across Europe and the United Arab Emirates
https://www.marketwatch.com/press-release/mainz-biomed-targets-multi-billion-dollar-sales-opportunities-with-best-in-class-cancer-screening-diagnostics-mynz-2022-09-26

[BlazingStocks]

$MYNZ trading low volume compared to its 10-day average volume within the first hour...BUT UP almost 3% at the high of the day.

[budfoxfun]

Getting close to a breakout here! $MYNZ

[pumpnass]

Let’s keep it going!

[budfoxfun]

$MYNZ Appointed Darin Leigh, former Abbott and Luminex executive, as Chief Commercial Officer

[budfoxfun]

Green to start the week here!

$MYNZ

[Mrogers23]

Indeed

[BlazingStocks]

$MYNZ diagnostics products are impressive...
*Provide multiple shots on revenue-generating goals
*ColoAlert colorectal cancer diagnostic test, which targets a massive market opportunity.
*Another value driver in PancAlert; its pancreatic cancer detection test, which also reached multiple preclinical milestones.
https://www.marketwatch.com/press-release/mainz-biomed-targets-multi-billion-dollar-sales-opportunities-with-best-in-class-cancer-screening-diagnostics-mynz-2022-09-26

[BlazingStocks]

Great article... nice close yesterday, looking for a continuation today.

[Mrogers23]

Biotech Stocks could be recession proof as bond market plunges (MYNZ, RVNC, AXSM, ABBV) - CinCor Pharma (NASDAQ:CINC), Axsome Therapeutics (NASDAQ:AXSM) - Benzinga
https://www.benzinga.com/pressreleases/22/09/ab29002308/biotech-stocks-could-be-recession-proof-as-bond-market-plunges-mynz-rvnc-axsm-abbv

[BlazingStocks]

$MYNZ new high of the day, UP almost 8% at $7.40, on News today!

News September 26, 2022

Mainz Biomed Targets Multi-Billion Dollar Sales Opportunities With Best-In-Class Cancer Screening Diagnostics ($MYNZ) https://www.marketwatch.com/press-release/mainz-biomed-targets-multi-billion-dollar-sales-opportunities-with-best-in-class-cancer-screening-diagnostics-mynz-2022-09-26

[BlazingStocks]

$MYNZ new high of the day on the ASK, up nearly 3% as we start Power Hour!

[budfoxfun]

$MYNZ green in power hour, could see a gap up!

[BlazingStocks]

$MYNZ looking good as lunchtime edges to a close... trading just under 25% of its 10-day average volume, BUT UP almost 2% @$7.

Article September 26, 2022

There’s No Doubt About It, Early Detection Saves Lives Mainz Biomed N.V. (NASDAQ:MYNZ)
https://investorbrandmedia.com/mynz-stock-alert/

[budfoxfun]

7.10 ready to go, thin here to a new high of day!

$MYNZ

[pumpnass]

Holding green

[BlazingStocks]

$MYNZ BID now higher than the current price...

mRNA Biomarkers - The Company Recently Acquired Exclusive Rights To Novel mRNA BBiomarkers

[pumpnass]

Agreed bro!

[budfoxfun]

Wow huge news to start the week! Sep 26, 2022 (AB Digital via COMTEX) -- Mainz Biomed (NASDAQ: MYNZ) stock may present a value investment opportunity too good to ignore. In fact, a move higher is the likely path of least resistance for this thinly traded molecular genetics diagnostics company. They have a well-fortified balance sheet, best-in-class early cancer detection tests, and a management team that's part of a Who's Who list in biotech management fueling that proposition.

But there's more to validate that case. Like most smallcap biotechs in this turbulent market, MYNZ stock has disconnected from its fundamentals and pushed lower despite reaching milestones. These include successfully raising $25.8 million (gross) in new capital, having less than $1 million in long-term debt, and generating revenues from an early cancer detection diagnostics portfolio.

Those diagnostics products, their primary value drivers, are impressive. They also provide multiple shots on revenue-generating goals. And not just from its flagship ColoAlert colorectal cancer diagnostic test, which targets a massive market opportunity. They have another value driver in PancAlert; its pancreatic cancer detection test. It also reached multiple preclinical milestones supporting its development as a first-in-class diagnostic for this deadly cancer indication.

Thus, positioned better than at any time in history to accelerate growth, with cash and products supporting its mission, MYNZ is an investment consideration based on merit, not hype. $MYNZ

[pumpnass]

Mainz Biomed Targets Multi-Billion Dollar Sales Opportunities With Best-In-Class Cancer Screening Diagnostics $MYNZ

https://www.marketwatch.com/press-release/mainz-biomed-targets-multi-billion-dollar-sales-opportunities-with-best-in-class-cancer-screening-diagnostics-mynz-2022-09-26?reflink=mw_share_twitter

[BlazingStocks]

$MYNZ News September 26, 2022

Mainz Biomed Targets Multi-Billion Dollar Sales Opportunities With Best-In-Class Cancer Screening Diagnostics ($MYNZ) https://www.marketwatch.com/press-release/mainz-biomed-targets-multi-billion-dollar-sales-opportunities-with-best-in-class-cancer-screening-diagnostics-mynz-2022-09-26

[BlazingStocks]

Premarket looked pretty good!

[BlazingStocks]

Might be an opportunity to get some cheaper shares this morning. These prices are a good deal in the long term.

[budfoxfun]

Super thin ask, this can move big.

$MYNZ

[pumpnass]

Nice and green today in pre market

[budfoxfun]

$MYNZ news alert: The Biotech Stocks that could be recession proof as bond market plunges https://www.marketwatch.com/press-release/biotech-stocks-could-be-recession-proof-as-bond-market-plunges-mynz-rvnc-axsm-abbv-2022-09-26?reflink=mw_share_twitter

[budfoxfun]

$MYNZ 127% year-over-year increase in ColoAlert revenue

[budfoxfun]

Should see a nice move from these levels!

$MYNZ

[BlazingStocks]

$MYNZ - Executed a $25.8 million (gross) public follow-on offering.
https://finance.yahoo.com/news/mainz-biomed-reports-first-half-070100420.html

[Acura979]

I'll take 600%, sit back and relaxed

[BlazingStocks]

$MYNZ looking better as we head into the last 30 minutes of the day...

[BlazingStocks]

Great point... The stock market, crypto market and housing market are getting crushed. But when blood in the streets.

Great opportunity here with $MYNZ

[BlazingStocks]

$MYNZ - A high-profile partnerships with leading laboratory Labor MVZ Dr. Stein + Kollegen, commonly referred to as “Laboratory Mönchengladbach” (February), one of the largest diagnostics laboratories in Germany, servicing over 2,500 physicians, processing over five million samples annually and screening approximately 1,000 patients per week specifically for CRC.
https://finance.yahoo.com/news/mainz-biomed-reports-first-half-070100420.html

[starkd748]

Chart is fubar....I will wait for a 600% haircut never catch a falling knife

[pumpnass]

It’s market conditions that every stock is dealing with right now. Smart money is DCAing. Anyone with cash will make huge gains when the market turns back positive

[BlazingStocks]

$MNYZ trading 35% over its 10-day average volume...ColoAlert, (NASDAQ: $MYNZ), has a specificity of 92% while ColoGuard, (NASDAQ: $EXAS), is at 87%!

*ColoAlert utilizes proprietary methods to analyze the cell DNA for specific tumor markers.

[starkd748]

Try 600%

[BlazingStocks]

$MYNZ nice bounce off the low this morning, with BID and ASK spread tightened

[starkd748]

Fell below support..Fell below 50ma 100ma 200ma to 52 week lows..
ITS A FALLING KNIFE...ITS GOING BELOW at least another 600% down...Wouldn't touch this one ITS done...

[BlazingStocks]

ColoAlert Holds Potential as a Blockbuster Early Detection Test for Colorectal Cancer and Could Turn Mainz Biomed (NASDAQ: $MYNZ) into One of the Biggest GROUND-FLOOR Success Stories on Wall Street!

[pumpnass]

Mainz Biomed Appoints Dr. Douglas Rex to its Medical Advisory Board

https://finance.yahoo.com/news/mainz-biomed-appoints-dr-douglas-070100627.html

[BlazingStocks]

$MYNZ - Achieved multiple preclinical milestones supporting the continued development of PancAlert, a potential first-in-class screening test for pancreatic cancer.
https://finance.yahoo.com/news/mainz-biomed-reports-first-half-070100420.html

[BlazingStocks]

Nice rebound off the low of the day... $MYNZ

[Elgordo84]

Get out while you can
This about to drop 50% from here.

[budfoxfun]

$MYNZ a $3.7 Billion Market Opportunity https://www.l3opptrk.com/3J67C1/3T3PPKJ/

[BlazingStocks]

$MYNZ holding steady, trading over 40% of its 10-day average volume, down slightly...

ColoAlert, Mainz Biomed's flagship product, combines the advantages of a colonoscopy and an occult blood test.
https://www.l3opptrk.com/3J67C1/3T3PPKJ/

[BlazingStocks]

$MYNZ trading nearly 2x over its average volume as we approach the last 30 minutes of the day... UP almost 16%!

[budfoxfun]

$MYNZ another strong close coming!

[budfoxfun]

+16.31% green in power hour!

MYNZ